{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T08:56:07Z","timestamp":1788944167910,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T00:00:00Z","timestamp":1688947200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100019507","name":"Ortho Dermatologics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019507","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.jaad.2022.08.069","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T05:00:12Z","timestamp":1693544412000},"page":"927-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clindamycin phosphate 1.2%\/adapalene 0.15%\/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials"],"prefix":"10.1016","volume":"89","author":[{"given":"Linda","family":"Stein Gold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Lain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Q.","family":"Del Rosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe D.","family":"Draelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence F.","family":"Eichenfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Sadick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William P.","family":"Werschler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda J.","family":"Gooderham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Lupo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.jaad.2022.08.069_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1346-8138.1991.tb03122.x","article-title":"Pathogenesis and pathogenesis related treatment of acne","volume":"18","author":"Gollnick","year":"1991","journal-title":"J Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.069_bib2","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.jaad.2015.12.037","article-title":"Guidelines of care for the management of acne vulgaris","volume":"74","author":"Zaenglein","year":"2016","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.08.069_bib3","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.2147\/PPA.S117437","article-title":"Interventions to increase adherence to acne treatment","volume":"10","author":"Moradi Tuchayi","year":"2016","journal-title":"Patient Prefer Adherence"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.069_bib5","first-page":"15","article-title":"A review of the anti-inflammatory properties of clindamycin in the treatment of acne vulgaris","volume":"85","author":"Del Rosso","year":"2010","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.069_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-50746-4","article-title":"In\u00a0vitro antimicrobial activity of acne drugs against skin-associated bacteria","volume":"9","author":"Blaskovich","year":"2019","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.jaad.2022.08.069_bib7","first-page":"5","article-title":"Benzoyl peroxide: enhancing antibiotic efficacy in acne management","volume":"15","author":"Dutil","year":"2010","journal-title":"Skin Therapy Lett"},{"issue":"6 Pt 2","key":"10.1016\/j.jaad.2022.08.069_bib8","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/S0190-9622(97)70050-1","article-title":"Pharmacology and chemistry of adapalene","volume":"36","author":"Shroot","year":"1997","journal-title":"J Am Acad Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.069_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40257-021-00594-8","article-title":"50 years of topical retinoids for acne: evolution of treatment","volume":"22","author":"Baldwin","year":"2021","journal-title":"Am J Clin Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.069_bib10","first-page":"417","article-title":"Antibiotic-resistant propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%","volume":"82","author":"Leyden","year":"2008","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2022.08.069_bib11","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/CCID.S359055","article-title":"Minimum contact time of 1.25%, 2.5%, 5%, and 10% benzoyl peroxide for a bactericidal effect against cutibacterium acnes","volume":"15","author":"Boonchaya","year":"2022","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.08.069_bib12","first-page":"s148","article-title":"Polymeric emulsion technology applied to tretinoin","volume":"18","author":"Kircik","year":"2019","journal-title":"J Drugs Dermatol"},{"issue":"6","key":"10.1016\/j.jaad.2022.08.069_bib13","first-page":"s6","article-title":"Topical vehicle formulations in the treatment of acne","volume":"17","author":"Hoffman","year":"2018","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2022.08.069_bib14","unstructured":"Tanghetti EA, Draelos ZD, Grimes P. Moisturizer use enhances facial tolerability of tazarotene 0.1% cream without compromising efficacy in patients with acne vulgaris. Poster presented at: Fall Clinical Dermatology, Las Vegas, NV, October 2008."},{"issue":"1","key":"10.1016\/j.jaad.2022.08.069_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40257-021-00650-3","article-title":"Efficacy and safety of a fixed-dose clindamycin phosphate 1.2%, benzoyl peroxide 3.1%, and adapalene 0.15% gel for moderate-to-severe acne: a randomized phase II study of the first triple-combination drug","volume":"23","author":"Stein Gold","year":"2022","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.069_bib17","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00128071-200102010-00006","article-title":"Comparison of the efficacy and safety of a combination topical gel formulation of benzoyl peroxide and clindamycin with benzoyl peroxide, clindamycin and vehicle gel in the treatments of acne vulgaris","volume":"2","author":"Leyden","year":"2001","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.069_bib18","first-page":"165","article-title":"A combination benzoyl peroxide and clindamycin topical gel compared with benzoyl peroxide, clindamycin phosphate, and vehicle in the treatment of acne vulgaris","volume":"67","author":"Tschen","year":"2001","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2022.08.069_bib19","series-title":"Duac\u00ae [Package Insert]","year":"2013"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.069_bib20","first-page":"110","article-title":"A North American study of adapalene-benzoyl peroxide combination gel in the treatment of acne","volume":"84","author":"Gold","year":"2009","journal-title":"Cutis"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.069_bib21","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.jaad.2008.06.040","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 2.5% for the once-daily treatment of moderate to severe acne vulgaris: assessment of efficacy and safety in 2813 patients","volume":"59","author":"Thiboutot","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"9","key":"10.1016\/j.jaad.2022.08.069_bib22","first-page":"1083","article-title":"An aqueous gel fixed combination of clindamycin phosphate 1.2% and benzoyl peroxide 3.75% for the once-daily treatment of moderate to severe acne vulgaris","volume":"13","author":"Pariser","year":"2014","journal-title":"J Drugs Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.069_bib23","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s40257-016-0178-4","article-title":"Moderate and severe inflammatory acne vulgaris effectively treated with single-agent therapy by a new fixed-dose combination adapalene 0.3 %\/benzoyl peroxide 2.5 % gel: a randomized, double-blind, parallel-group, controlled study","volume":"17","author":"Stein Gold","year":"2016","journal-title":"Am J Clin Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.069_bib24","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jaad.2007.06.006","article-title":"Adapalene-benzoyl peroxide, a fixed-dose combination for the treatment of acne vulgaris: results of a multicenter, randomized double-blind, controlled study","volume":"57","author":"Thiboutot","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2022.08.069_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jdin.2020.12.006","article-title":"Real-world adherence to topical therapies in patients with moderate acne","volume":"2","author":"Lam Hoai","year":"2021","journal-title":"JAAD Int"},{"issue":"7","key":"10.1016\/j.jaad.2022.08.069_bib26","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1177\/0300060519847367","article-title":"Topical treatment of acne vulgaris: efficiency, side effects, and adherence rate","volume":"47","author":"Sevimli Dikicier","year":"2019","journal-title":"J Int Med Res"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.069_bib27","first-page":"91","article-title":"Randomized, observer-blind, split-face study to compare the irritation potential of 2 topical acne formulations\u00a0over a 14-day treatment period","volume":"90","author":"Ting","year":"2012","journal-title":"Cutis"},{"issue":"5","key":"10.1016\/j.jaad.2022.08.069_bib28","first-page":"16","article-title":"The tolerability profile of clindamycin 1%\/benzoyl peroxide 5% gel vs. adapalene 0.1%\/benzoyl peroxide 2.5% gel for facial acne: results of two randomized, single-blind, split-face studies","volume":"5","author":"Green","year":"2012","journal-title":"J Clin Aesthet Dermatol"},{"issue":"4","key":"10.1016\/j.jaad.2022.08.069_bib29","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/jocd.12013","article-title":"The tolerability profile of clindamycin 1%\/benzoyl peroxide 5% gel vs. adapalene 0.1%\/benzoyl peroxide 2.5% gel for facial acne: results of a randomized, single-blind, split-face study","volume":"11","author":"Gonzalez","year":"2012","journal-title":"J Cosmet Dermatol"},{"issue":"3","key":"10.1016\/j.jaad.2022.08.069_bib30","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/bjd.20080","article-title":"Topical preparations for the treatment of mild-to-moderate acne vulgaris: systematic review and network meta-analysis","volume":"185","author":"Stuart","year":"2021","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.jaad.2022.08.069_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/jdv.16686","article-title":"Antibiotic resistance in acne: changes, consequences and concerns","volume":"35","author":"Karadag","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.jaad.2022.08.069_bib32","first-page":"103","article-title":"Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial","volume":"86","author":"Yentzer","year":"2010","journal-title":"Cutis"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222301201X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S019096222301201X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:27:18Z","timestamp":1759274838000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S019096222301201X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S019096222301201X"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.08.069","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clindamycin phosphate 1.2%\/adapalene 0.15%\/benzoyl peroxide 3.1% gel for moderate-to-severe acne: Efficacy and safety results from two randomized phase 3 trials","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.08.069","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}